Vimarsana
Biggest News Aggregation in the World

Page 11 - Chuck Kummeth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chuck Kummeth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chuck Kummeth Today - Breaking & Trending Today

Bio-Techne Releases First Quarter Fiscal 2022 Results - Vimarsana News

Bio-Techne Releases First Quarter Fiscal 2022 Results

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021. First Quarter FY2022...

BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2022 RESULTS - Form 8-K - Vimarsana News

BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2022 RESULTS - Form 8-K

BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2022 RESULTS Minneapolis/November 2, 2021/ Bio-Techne Corporation today reported its financial results for the first quarter ended... | November 2, 2021

Bio-Techne Corporation (TECH) Q1 2022 Earnings Call Transcript - Vimarsana News

Bio-Techne Corporation (TECH) Q1 2022 Earnings Call Transcript

TECH earnings call for the period ending September 30, 2021.

Source: fool.com
Bio-Techne Announces ExoDx Prostate Test Data Publication in the Journal of Prostate Cancer and Prostatic Diseases - Vimarsana News

Bio-Techne Announces ExoDx Prostate Test Data Publication in the Journal of Prostate Cancer and Prostatic Diseases

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has published important clinical research in...

Kantaro's Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under the COVID-19 Interim Order - Vimarsana News

Kantaro's Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under the COVID-19 Interim Order

Share this article   - COVID-SeroKlir detects both the presence and precise level of neutralizing IgG antibodies with 98.8% sensitivity and 99.6% specificity- -Available immediately and can be used in Canadian laboratories without proprietary equipment- NEW YORK, June 2, 2021 /PRNewswire/ -- Kantaro Biosciences, LLC (Kantaro), a joint venture between the Mount Sinai Health System and RenalytixAI (LSE: RENS /NASDAQ: RNLX), and its commercial partner Bio-Techne Corporation (NASDAQ: TECH), have received Health Canada Authorization under the COVID-19 Interim Order for COVID-SeroKlir, its semi-q...